Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1 Suppl 44
pubmed:dateCreated
2007-4-12
pubmed:abstractText
Rituximab, an anti-CD20 biotherapy, has been effective against refractory and/or relapsing Wegener's granulomatosis (WG). But the frequency of and time to responses to rituximab, and its effects on various clinical WG manifestations remain to be thoroughly evaluated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S23-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17428359-Adult, pubmed-meshheading:17428359-Aged, pubmed-meshheading:17428359-Antibodies, Antineutrophil Cytoplasmic, pubmed-meshheading:17428359-Antibodies, Monoclonal, pubmed-meshheading:17428359-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:17428359-Drug Therapy, Combination, pubmed-meshheading:17428359-Female, pubmed-meshheading:17428359-Glucocorticoids, pubmed-meshheading:17428359-Humans, pubmed-meshheading:17428359-Immunologic Factors, pubmed-meshheading:17428359-Immunosuppressive Agents, pubmed-meshheading:17428359-Male, pubmed-meshheading:17428359-Middle Aged, pubmed-meshheading:17428359-Recurrence, pubmed-meshheading:17428359-Remission Induction, pubmed-meshheading:17428359-Retrospective Studies, pubmed-meshheading:17428359-Severity of Illness Index, pubmed-meshheading:17428359-Treatment Failure, pubmed-meshheading:17428359-Wegener Granulomatosis
pubmed:articleTitle
Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
pubmed:affiliation
French Vasculitis Study Group, Department of Internal Medicine, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université Paris 5-René-Descartes, Paris, France.
pubmed:publicationType
Journal Article